Annual CFF:
$164.00M+$122.04M(+290.92%)Summary
- As of today, TERN annual cash from financing is $164.00 million, with the most recent change of +$122.04 million (+290.92%) on December 31, 2024.
- During the last 3 years, TERN annual cash from financing has risen by +$29.60 million (+22.03%).
- TERN annual cash from financing is now -1.86% below its all-time high of $167.09 million, reached on December 31, 2022.
Performance
TERN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
$0.00-$318.00K(-100.00%)Summary
- As of today, TERN quarterly cash from financing is $0.00, with the most recent change of -$318.00 thousand (-100.00%) on September 30, 2025.
- Over the past year, TERN quarterly cash from financing has dropped by -$163.37 million (-100.00%).
- TERN quarterly cash from financing is now -100.00% below its all-time high of $163.37 million, reached on September 30, 2024.
Performance
TERN Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$1.01M-$163.37M(-99.39%)Summary
- As of today, TERN TTM cash from financing is $1.01 million, with the most recent change of -$163.37 million (-99.39%) on September 30, 2025.
- Over the past year, TERN TTM cash from financing has dropped by -$176.62 million (-99.43%).
- TERN TTM cash from financing is now -99.48% below its all-time high of $195.78 million, reached on June 30, 2023.
Performance
TERN TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
TERN Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +290.9% | -100.0% | -99.4% |
| 3Y3 Years | +22.0% | -100.0% | -98.4% |
| 5Y5 Years | +10000.0% | - | - |
TERN Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -1.9% | +290.9% | -100.0% | at low | -99.5% | at low |
| 5Y | 5-Year | -1.9% | >+9999.0% | -100.0% | +100.0% | -99.5% | at low |
| All-Time | All-Time | -1.9% | >+9999.0% | -100.0% | +100.0% | -99.5% | +3157.6% |
TERN Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $0.00(-100.0%) | $1.01M(-99.4%) |
| Jun 2025 | - | $318.00K(+329.7%) | $164.38M(-0.0%) |
| Mar 2025 | - | $74.00K(-88.0%) | $164.46M(+0.0%) |
| Dec 2024 | $164.00M(+290.9%) | $617.00K(-99.6%) | $164.38M(-7.5%) |
| Sep 2024 | - | $163.37M(>+9900.0%) | $177.63M(+1143.8%) |
| Jun 2024 | - | $399.00K(>+9900.0%) | $14.28M(-0.6%) |
| Mar 2024 | - | $0.00(-100.0%) | $14.37M(-66.0%) |
| Dec 2023 | $41.95M(-74.9%) | $13.86M(>+9900.0%) | $42.30M(-68.6%) |
| Sep 2023 | - | $20.00K(-95.9%) | $134.66M(-31.2%) |
| Jun 2023 | - | $489.00K(-98.2%) | $195.78M(+0.2%) |
| Mar 2023 | - | $27.92M(-73.7%) | $195.42M(+16.7%) |
| Dec 2022 | $167.09M | $106.23M(+73.7%) | $167.50M(+161.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $61.15M(>+9900.0%) | $64.01M(+1649.8%) |
| Jun 2022 | - | $124.00K(>+9900.0%) | $3.66M(+88.1%) |
| Mar 2022 | - | $0.00(-100.0%) | $1.95M(-98.6%) |
| Dec 2021 | $134.39M(+57.2%) | $2.74M(+243.4%) | $137.11M(+2.0%) |
| Sep 2021 | - | $797.00K(+150.2%) | $134.38M(+0.6%) |
| Jun 2021 | - | -$1.59M(-101.2%) | $133.58M(-12.1%) |
| Mar 2021 | - | $135.17M(+701.0%) | $152.04M(+802.7%) |
| Dec 2020 | $85.52M(>+9900.0%) | - | - |
| Jun 2020 | - | $16.88M(>+9900.0%) | $16.84M(>+9900.0%) |
| Mar 2020 | - | -$33.00K | -$33.00K |
| Dec 2019 | $62.00K(-99.9%) | - | - |
| Dec 2018 | $99.76M | - | - |
FAQ
- What is Terns Pharmaceuticals, Inc. annual cash from financing?
- What is the all-time high annual cash from financing for Terns Pharmaceuticals, Inc.?
- What is Terns Pharmaceuticals, Inc. annual cash from financing year-on-year change?
- What is Terns Pharmaceuticals, Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Terns Pharmaceuticals, Inc.?
- What is Terns Pharmaceuticals, Inc. quarterly cash from financing year-on-year change?
- What is Terns Pharmaceuticals, Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for Terns Pharmaceuticals, Inc.?
- What is Terns Pharmaceuticals, Inc. TTM cash from financing year-on-year change?
What is Terns Pharmaceuticals, Inc. annual cash from financing?
The current annual cash from financing of TERN is $164.00M
What is the all-time high annual cash from financing for Terns Pharmaceuticals, Inc.?
Terns Pharmaceuticals, Inc. all-time high annual cash from financing is $167.09M
What is Terns Pharmaceuticals, Inc. annual cash from financing year-on-year change?
Over the past year, TERN annual cash from financing has changed by +$122.04M (+290.92%)
What is Terns Pharmaceuticals, Inc. quarterly cash from financing?
The current quarterly cash from financing of TERN is $0.00
What is the all-time high quarterly cash from financing for Terns Pharmaceuticals, Inc.?
Terns Pharmaceuticals, Inc. all-time high quarterly cash from financing is $163.37M
What is Terns Pharmaceuticals, Inc. quarterly cash from financing year-on-year change?
Over the past year, TERN quarterly cash from financing has changed by -$163.37M (-100.00%)
What is Terns Pharmaceuticals, Inc. TTM cash from financing?
The current TTM cash from financing of TERN is $1.01M
What is the all-time high TTM cash from financing for Terns Pharmaceuticals, Inc.?
Terns Pharmaceuticals, Inc. all-time high TTM cash from financing is $195.78M
What is Terns Pharmaceuticals, Inc. TTM cash from financing year-on-year change?
Over the past year, TERN TTM cash from financing has changed by -$176.62M (-99.43%)